Albert Seymour - See Remarks, Homology Medicines, Inc
As of April 21, 2022
What is Albert Seymour's Net Worth?
The current estimated net worth of Homology Medicines, Inc's See Remarks, Albert Seymour, is estimated to be about $1.92M . Albert Seymour owns about 131,646 units of Homology Medicines, Inc common stock. In the last 4 years at Homology Medicines, Inc, Albert Seymour has sold an estimated value of $1.65M worth.
What is Albert Seymour's Past Insider Trading?
Albert Seymour's largest sale order was 18,600 units , worth over $300.36K on December 3, 2019. In total, Albert Seymour has made about 16 transactions over 4 years of their time at Homology Medicines, Inc. Albert Seymour usually trades in January, with the busiest year in 2019. The most recent transaction was a sale order of 1,661 units , worth over $6.28K on January 12, 2022.
Albert Seymour
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Albert Seymour's Salary in 2020?
As See Remarks of Homology Medicines, Inc, Albert Seymour has a total base salary of $426,800 . Albert Seymour received compensation valued at about $607,577 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of other earnings, plans or compensations of $170,720 , and other compensation of $10,057 .
What is Albert Seymour's' Mailing Address?
- Mailing address is C/o Homology Medicines, Inc. One Patriots Park Bedford MA 01730 MA
Homology Medicines, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Arthur O. Tzianabos, Ph.D. | 2020 | $563,200 | - | - | $309,760 | $13,000 | $885,960 |
| Arthur O. Tzianabos, Ph.D. | 2019 | $537,600 | - | $4,217,097 | $295,680 | $12,500 | $5,062,877 |
| Albert Seymour, Ph.D. | 2020 | $426,800 | - | - | $170,720 | $10,057 | $607,577 |
| Albert Seymour, Ph.D. | 2019 | $405,600 | - | $1,295,756 | $162,240 | $13,231 | $1,876,827 |
| W. Bradford Smith | 2020 | $406,700 | - | - | $162,680 | $13,000 | $582,380 |
| W. Bradford Smith | 2019 | $384,200 | - | $1,307,536 | $153,680 | $14,880 | $1,860,296 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1661998/000156459021021931/fixx-def14a_20210617.htm
What are Homology Medicines, Inc's Past Insider Trades?
Homology Medicines, Inc's most recent insider trade came on January 12, 2022 by W. Bradford Smith who sold 2,182 units worth $8.25K . In the last 4 years, insiders at Homology Medicines, Inc have sold an estimated value of $109.51M and bought an estimated value of $60.18M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Albert Seymour, See Remarks, Timothy P Kelly, Chief Operating Officer, and Arthur Tzianabos, President & CEO .
Homology Medicines, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||